Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) P/B ratio
As of 16 October 2026, Solventum Corporation (SOLV) trades at a P/B ratio of 3.1×. Over the past ten years it has ranged from 1.0× (March 2024) to 4.9× (February 2025); the current reading is higher than 45% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 2.7× | (29.35%) |
| FY2024 | 3.9× | 226.50% |
| FY2023 | 1.2× | 0.00% |
| FY2022 | 1.2× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2.8× | 21.30% |
| Mar 2026 | 2.3× | (16.22%) |
| Dec 2025 | 2.7× | 7.05% |
| Sep 2025 | 2.6× | (29.55%) |
| 10 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| COO The Cooper Companies, Inc. compare | 1.3× |
| ALC Alcon compare | 1.5× |
| AVTR Avantor, Inc. compare | 2.0× |
| BAX Baxter International Inc. compare | 2.1× |
| ALGN Align Technology, Inc. compare | 2.5× |
| ATR AptarGroup, Inc. compare | 3.0× |
| SOLV Solventum Corporation | 3.1× |
| RGEN Repligen Corporation compare | 4.7× |
| WST West Pharmaceutical Services, Inc. compare | 9.1× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement